Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will participate in a fireside chat during the Goldman Sachs Recovery Inoculated: The Current Outlook for COVID-19 Vaccines, ...
Scandit, the leading technology platform for mobile computer vision and augmented reality (AR) solutions for enterprises, has signed a national contract with NHS Digital to provide data capture services as part of the UK’s response ...
A common antiparasitic drug could block lung damage in people with coronavirus, according to new research part-funded by the British Heart Foundation (BHF) and published in Nature. Using robotic technology to screen over 3,000 approved drugs ...
Popular Posts
